|
Market Closed -
Nasdaq
00:00:00 31/10/2026 +04
|
5-day change | 1st Jan Change | ||
| 16.75 USD | -4.72% |
|
-12.58% | -45.03% |
| 10-28 | Beta Bionics, Inc., Q3 2026 Earnings Call, Oct 27, 2026 | |
| 10-28 | Earnings Flash (BBNX) Beta Bionics Posts Q3 Per-Share Loss $0.52, vs. FactSet Est of $0.52 Loss | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Advanced Medical Equipment & Technology
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 956M | - | ||||
| 262B | |||||
| 167B | |||||
| 156B | |||||
| 61.87B | |||||
| 54.44B |
- Stock Market
- Stocks
- BBNX Stock
- Charts Beta Bionics, Inc.
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
